Enhanced Vs Standard Dermatologic Management with Amivantamab-Lazertinib in Advanced NSCLC: Phase 2 COCOON StudyB. C. Cho,N. Girard, M. B. Sauder, J. Feldman, W. Li,F. Bozorgmehr,M. Mak, J. Smith, J. Simoes,P. Mahadevia, B. G. Anderson, T. Romero, K. Xia, G. Wang, S. Murphy,J. M. Bauml,A. I. SpiraJOURNAL OF THORACIC ONCOLOGY（2024）引用 0|浏览2AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
